home / stock / arwr / arwr short
Short Information | Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,519,104 |
Total Actual Volume | 19,481,850 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 125,955 |
Average Short Percentage | 13.31% |
Is there a ARWR Short Squeeze or Breakout about to happen?
See the ARWR Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-23-2024 | $28.6 | $28.78 | $29.24 | $28.4567 | 656,535 | 89,698 | 13.66% |
07-22-2024 | $28.47 | $28.75 | $28.9 | $27.83 | 742,532 | 122,392 | 16.48% |
07-19-2024 | $27.75 | $28.3 | $28.31 | $27.29 | 735,247 | 127,787 | 17.38% |
07-18-2024 | $28.02 | $27.64 | $28.99 | $27.22 | 967,822 | 162,987 | 16.84% |
07-17-2024 | $28.7 | $28.02 | $28.97 | $27.73 | 1,317,187 | 364,744 | 27.69% |
07-16-2024 | $28.98 | $29.54 | $30.41 | $28.77 | 1,394,144 | 196,368 | 14.09% |
07-15-2024 | $28.31 | $28.86 | $29.0799 | $27.84 | 768,679 | 108,144 | 14.07% |
07-12-2024 | $28.75 | $28.11 | $28.7595 | $27.9 | 809,668 | 94,138 | 11.63% |
07-11-2024 | $27.64 | $28.25 | $28.79 | $27.19 | 1,547,121 | 181,428 | 11.73% |
07-10-2024 | $25.4 | $26.82 | $26.83 | $25.09 | 936,164 | 139,645 | 14.92% |
07-09-2024 | $25.55 | $25.35 | $26.19 | $25.2906 | 848,983 | 84,885 | 10% |
07-08-2024 | $25.99 | $25.57 | $26.26 | $25.31 | 745,442 | 82,356 | 11.05% |
07-05-2024 | $24.79 | $25.57 | $25.695 | $24.57 | 622,199 | 80,676 | 12.97% |
07-03-2024 | $25.6 | $25.07 | $26 | $24.85 | 360,989 | 44,873 | 12.43% |
07-02-2024 | $25.91 | $25.22 | $25.91 | $24.9 | 806,436 | 102,372 | 12.69% |
07-01-2024 | $25.67 | $26.05 | $26.96 | $25.58 | 979,124 | 101,298 | 10.35% |
06-28-2024 | $25.76 | $25.99 | $26.04 | $24.88 | 2,315,874 | 98,631 | 4.26% |
06-27-2024 | $26.36 | $25.69 | $26.405 | $25.58 | 811,411 | 71,416 | 8.8% |
06-26-2024 | $26.78 | $26.26 | $26.78 | $25.89 | 1,020,539 | 131,623 | 12.9% |
06-25-2024 | $27.1 | $26.87 | $27.8 | $26.65 | 1,095,754 | 133,643 | 12.2% |
News, Short Squeeze, Breakout and More Instantly...
Arrowhead Pharmaceuticals Inc. Company Name:
ARWR Stock Symbol:
NASDAQ Market:
Arrowhead Pharmaceuticals Inc. Website:
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 8, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal third quarter ended June 30, 2024. Webcast and Conference Call and Details Investors may ac...
– Based on promising results in the Phase 2 MUIR clinical study, the Phase 3 CAPITAN trial is designed to enroll patients with mixed hyperlipidemia and residual risk of atherosclerotic cardiovascular disease – CAPITAN builds upon existing SUMMIT program of pivotal Phase 3 clinical...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of obesity and metabolic diseases, were presented at the American Diabetes Association (ADA) 84 th Scientific Sessions, which were held J...